D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial-Reference-Cited by-同舟云学术

D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial

Published:2014-04 Issue:4 Volume:12 Page:479-487
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Cohen A. T.¹,Spiro T.E.²,Spyropoulos A. C.³,DeSanctis Y. H.²,Homering M.⁴,Büller H. R.⁵,Haskell L.⁶,Hu D.⁷,Hull R.⁸,Mebazaa A.⁹,Merli G.¹⁰,Schellong S.¹¹,Tapson V. F.¹²,Burton P.⁶,

Affiliation:

1. King's College Hospital; London UK

2. Bayer HealthCare Inc.; Whippany NJ USA

3. Hofstra North Shore-LIJ School of Medicine; Hempstead NY USA

4. Bayer HealthCare; Wuppertal Germany

5. Academic Medical Center; Amsterdam the Netherlands

6. Janssen Research Development; LLC; Raritan NJ USA

7. People's Hospital of Peking University; Beijing China

8. Foothills Hospital; Calgary AB Canada

9. Saint Louis Lariboisière Hospitals; Paris France

10. Thomas Jefferson Hospitals; Philadelphia PA USA

11. Dresden-Friedrichstadt Hospital; Dresden Germany

12. Duke University Medical Center; Durham NC USA

Funder

Bayer HealthCare Pharmaceuticals and Janssen Research & Development

LLC

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12515/fullpdf

Reference21 articles.

1. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients;Cohen;Thromb Haemost,2005

2. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group;Samama;N Engl J Med,1999

3. MAGELLAN Investigators. Rivaroxaban for thromboprophylaxis in acutely ill medical patients;Cohen;N Engl J Med,2013

4. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial;Hull;Ann Intern Med,2010

5. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients;Goldhaber;N Engl J Med,2011

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical characteristics analysis of serum markers for the cardiovascular system in early-stage COVID-19 patients;Frontiers in Cardiovascular Medicine;2024-07-26

2. Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers;Annals of Hematology;2024-02-13

3. Post-operative venous thromboembolism in patients after extracranial otologic surgery: A case series;Journal of Otology;2024-01

4. VTE prevention in medical inpatients - Current approach and controversies;Thrombosis Update;2023-12

5. Biomarkers in pediatric venous thromboembolism: a systematic review of the literature;Journal of Thrombosis and Haemostasis;2023-07